孟山都公司清楚说明,该品种不是为美国而是为别国设计的、且在中国农业部闪批后才投入市场:
INTACTA RR2 PRO Soybeans。 http://www.monsanto.com/products ... 2-pro-soybeans.aspx
摘录:INTACTA RR2 PROTM soybean is the first biotechnology product developed especially for a market outside the United States. After 11 years of research and field trials, the soybeans hit the market for sale in July 2013. (摘录完)。
Monsanto Company Receives Final Key Regulatory Approval For Intacta RR2 PRO Soybeans, Setting Up Commercial Launch In Brazil 。
June 17, 2013。 http://www.prnewswire.com/news-r ... azil-211805611.html
摘录:Monsanto Company's first technology developed specifically for an international market, Intacta RR2 PRO soybeans, has received official approval from China's Ministry of Agriculture. With this approval, Monsanto will now begin commercial preparation for the full-scale launch of Intacta RR2 PROTM soybeans in Brazil for the upcoming crop season.……。
Technical Opinion no. 2542/2010 - Commercial release of genetically modified insect-resistant and herbicide-tolerant soy containing genetically modified events MON 87701 and MON 89788
Technical Opinion no. 2542/2010
连接:http://www.ctnbio.gov.br/index.php/content/view/15558.html
Dissenting Votes:
CTNBio members Doctor Pedro Canísio Binsfeld, Doctor Paulo Kageyama, Doctor Leonardo Melgarejo, Doctor Solange Telles da Silva, Doctor Graziela Almeida da Silva and Doctor Luiza Chomenko voted against commercial release of MON 87701 x MON 89788 soy. Doctor Melgarejo justifies his vote by claiming that some studies required by Ruling Resolution n? 5, including pregnant animals and multigenerational studies were not conducted. Doctor Solange Telles justifies her vote by claiming that the post-commercial release monitoring plan had not been previously passed. Doctor Luiza Chomenko justifies her vote by claiming that the post-commercial release monitoring plan had not been previously passed and that during the discussion on the proceedings a series of issues were raised about CTNBio procedures.
Abstentions: There were no abstentions. 截图: